S M Baumgartner-Parzer

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi request reprint Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Medical University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 90:775-8. 2005
  2. ncbi request reprint Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 92:1164-7. 2007
  3. ncbi request reprint Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 90:6232-6. 2005
  4. ncbi request reprint Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, University of Vienna, Waeringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 86:4771-5. 2001
  5. ncbi request reprint A rare duplicated 21-hydroxylase haplotype and a de novo mutation: a family analysis
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Clinical Endocrinology and Metabolism, University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 88:2794-6. 2003
  6. doi request reprint Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect
    S Kleinle
    Department of Internal Medicine III, Division of Clinical Endocrinology and Metabolism, Medical University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 94:3954-8. 2009
  7. ncbi request reprint Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas
    S M Baumgartner-Parzer
    Department of Internal Medicine III, University of Vienna, Austria
    Clin Endocrinol (Oxf) 56:811-6. 2002
  8. ncbi request reprint Determination of plasma ET-1 by RIA--risks and limitations
    S M Baumgartner-Parzer
    Department of Internal Medicine III, University of Vienna, Austria
    Horm Metab Res 30:633-5. 1998
  9. doi request reprint Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity
    K Tobler
    Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
    Int J Obes (Lond) 34:687-700. 2010
  10. ncbi request reprint Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism
    M Artwohl
    Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
    Diabetologia 48:586-94. 2005

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Medical University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 90:775-8. 2005
    ..In conclusion, the observed CAH carrier frequency of 9.5% suggests a higher prevalence of CAH heterozygosity in a middle European population than hitherto estimated independently of the individuals' Yugoslav or non-Yugoslav origin...
  2. ncbi request reprint Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 92:1164-7. 2007
    ..Whereas so far, only heterozygous deletions of the CYP21A1P pseudogene were seen as premutations for de novo aberrations, the present report addresses such a predisposing role for parental duplicated CYP21A2 genes...
  3. ncbi request reprint Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 90:6232-6. 2005
    ....
  4. ncbi request reprint Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Endocrinology and Metabolism, University of Vienna, Waeringer Guertel 18 20, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 86:4771-5. 2001
    ....
  5. ncbi request reprint A rare duplicated 21-hydroxylase haplotype and a de novo mutation: a family analysis
    S M Baumgartner-Parzer
    Department of Internal Medicine III, Division of Clinical Endocrinology and Metabolism, University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 88:2794-6. 2003
    ..This family analysis highlights the complexity of the CYP21/CYP21P(pseudogene) loci and the difficulties of 21-OH genotyping...
  6. doi request reprint Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect
    S Kleinle
    Department of Internal Medicine III, Division of Clinical Endocrinology and Metabolism, Medical University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 94:3954-8. 2009
    ....
  7. ncbi request reprint Increased prevalence of heterozygous 21-OH germline mutations in patients with adrenal incidentalomas
    S M Baumgartner-Parzer
    Department of Internal Medicine III, University of Vienna, Austria
    Clin Endocrinol (Oxf) 56:811-6. 2002
    ..We therefore performed an analysis of the prevalence of 21-OH germline mutations in patients with non-functional adrenal incidentalomas...
  8. ncbi request reprint Determination of plasma ET-1 by RIA--risks and limitations
    S M Baumgartner-Parzer
    Department of Internal Medicine III, University of Vienna, Austria
    Horm Metab Res 30:633-5. 1998
    ..Thus, this study clearly documents that ET-1 concentrations measured in plasma samples represent apparent concentrations which have to be interpreted with caution...
  9. doi request reprint Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity
    K Tobler
    Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
    Int J Obes (Lond) 34:687-700. 2010
    ....
  10. ncbi request reprint Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism
    M Artwohl
    Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
    Diabetologia 48:586-94. 2005
    ....
  11. ncbi request reprint Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia
    V Dolzan
    Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
    Eur J Endocrinol 153:99-106. 2005
    ....